A practical reference on actin-binding motif: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Supplied as a lyophilised cake in sealed vials |
| Solubility class | Freely soluble in water | Polar and charged side chains dominate the sequence |
| Typical storage temperature | -20 °C or below | Dry and dark; a desiccant is often recommended |
| Identity confirmation | Mass spectrometry | Observed mass compared with the theoretical value |
| Common synonyms | Thymosin beta-4 fragment | Also written as T beta 4 fragment 17-23 |
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
In early November 2020, Israel Hadassah Medical Center director-general Zeev Rotstein stated that Hadassah's branch in Moscow's Skolkovo Innovation Center was collaborating on a phase III clinical trial. The ongoing phase III study is a randomised, double-blind, placebo-controlled, multi-centre clinical trial involving 40,000 volunteers in Moscow, and is scheduled to run until May 2021. In 2020–2021, phase III clinical studies were also being conducted in Belarus, UAE, India, Kazakhstan and Venezuela. On 13 April 2021, India's health ministry said its drug regulator had found that safety and immunogenicity data from a local trial of Sputnik V coronavirus vaccine was comparable to that of a late-stage trial done in Russia.
=== Appeals === Since the amendment of the Criminal Procedure Code in 1992, all capital cases have been heard by a single judge in the High Court instead of two judges. After conviction and sentencing, the offender has the option of making an appeal to the Court of Appeal. If the appeal fails, the final recourse rests with the President of Singapore, who has the power to grant clemency on the advice of the Cabinet. In exceptional cases since 2012, the Court of Appeal would be asked to review its previous decisions in concluded criminal appeals where it was necessary to correct a miscarriage of justice, most of which involved drug cases attracting the death penalty. The exact number of successful appeals is unknown. In November 1995, one Poh Kay Keong had his conviction overturned after the court found that his statement to a Central Narcotics Bureau officer had been made under duress. Another was the case of Nadasan Chandra Secharan, who was initially found guilty of murder and condemned to death by the High Court in June 1996, but later acquitted of murder by the Court of Appeal in January 1997 after they found the evidence against him was insufficient to show that he had murdered his lover Ramapiram Kannickaisparry.
=== Blood thinners === The trend in skin surgery over the last 10 years has been to continue anticoagulants while performing skin surgery. Most cutaneous bleeding can be controlled with electrocautery, especially bipolar forceps. The benefit gained by ease of hemostasis is weighed against the risk of stopping anticoagulants; and it is generally preferred to continue anticoagulants.
Sources: en.wikipedia.org
Pure obsidian is usually dark in appearance, though the color varies depending on the impurities present. Iron and other transition elements may give the obsidian a dark brown to black color. Most black obsidians contain nanoinclusions of magnetite, an iron oxide. Very few samples of obsidian are nearly colorless. In some stones, the inclusion of small, white, radially clustered crystals (spherulites) of the mineral cristobalite in the black glass produce a blotchy or snowflake pattern (snowflake obsidian). Obsidian may contain patterns of gas bubbles remaining from the lava flow, aligned along layers created as the molten rock was flowing before being cooled. These bubbles can produce interesting effects such as a golden sheen (sheen obsidian). An iridescent, rainbow-like sheen (fire obsidian) is caused by inclusions of magnetite nanoparticles creating thin-film interference. Colorful, striped obsidian (rainbow obsidian) from Mexico contains oriented nanorods of hedenbergite, which cause the rainbow striping effects by thin-film interference.
==== Affordable healthy diets ==== Despite disruptions, a 2021 study by FAO highlights that agrifood systems need to continuously guarantee access to food for all. In addition to the nearly 3 billion people in 2019 who could not afford a healthy diet that protects against malnutrition in all its forms, an additional 1 billion people (mostly on lower- and upper-middle-income countries) are at risk of not affording a healthy diet if a shock were to reduce their income by a third. FAO suggests that low-income countries in dire need of improving the affordability of healthy diets should focus on adopting long-term approaches that improve income levels and lower the cost of nutritious foods. In middle-income countries with many at risk, building resilience through the stabilization of incomes and diversification of agrifood systems should be the focus instead. Social protection programmes can also be effective policy tools during times of crisis but should be designed with the key challenges in mind. Reyes et al. (2021) reviewed 12 global nutrition initiatives and found significant overlap in recommendations for a healthier food system. Their thematic analysis identified the following 13 different action themes, which are not necessarily mutually exclusive:
=== United States === In 2008, Pulver Spirits began developing a line of alcohol powder products to be marketed in the United States. The marketing was reportedly intended to be in full compliance with alcohol regulations and targeted at adults of legal drinking age. In Spring 2014, the Arizona-based company Lipsmark LLC announced that it would start marketing powdered alcohol under the name "Palcohol", a portmanteau of powder + alcohol. This caused considerable controversy, after the product was approved by the TTB for sale. This approval was later attributed to a "labeling error", and the manufacturer surrendered the approvals. In March, 2015, the U.S. Alcohol and Tobacco Tax and Trade Bureau (TTB) approved four powdered alcohol products with the brand name "Palcohol" for sale in the U.S. Under the Twenty-first Amendment to the United States Constitution, state and territory governments also have substantial regulatory powers over "intoxicating liquors", especially regarding retail sales and sales to minors. Shortly after the TTB approval was announced, the U.S. Food and Drug Administration (FDA) responded to inaccurate reports implying that it had approved powdered alcohol as being safe. The FDA clarified that its role was to evaluate the nonalcoholic ingredients and that based on its evaluation of specific powdered alcohol products it had no legal basis to block their entry into the U.S. market. In 2014, Ohio state legislators introduced legislation that would ban Palcohol and all other powdered alcohol. The following year, Iowa state legislators followed suit.
Sources: en.wikipedia.org
Canada (1974) Australia (1981) Israel (1983) UK (1987) Netherlands (2010) In 2012, JDF changed its name to Juvenile Diabetes Research Foundation, which was later shortened to JDRF. In 2019, JDRF International appointed its first-ever CEO and president with type 1 diabetes, Dr. Aaron Kowalski. In 2024, the international chapters of the organization began to change their name from JDRF to Breakthrough T1D, reflecting its focus on helping people of all ages and in line with growing awareness that T1D affects people of all ages. The Australian affiliate was the last to change their name on March 31, 2025.
Kropotkin, Peter Alexeivitch (1911). "Cossacks" . Encyclopædia Britannica. Vol. 7 (11th ed.). p. 218. "Cossacks during the Napoleonic Wars". "Zaporizhian Cossacks". "Encyclopedia of Ukraine". "History of Ukrainian Cossacks". "Encyclopedia of Ukraine". Soviet Cossacks (photography). Archived from the original on 2011-11-13. Retrieved 2010-07-27. – an issue of the propaganda journal USSR in Construction which presents numerous images of Cossack life in Soviet Russia. "Cossack Nation Live journal". {{cite web}}: Check |url= value (help) "Cossack Nation – The Social Network of Ethnic Cossacks". "The Congress of Cossacks in America". "Pirate, Rebel, Freedom Fighter, Champion of the Poor". Archived from the original on 2007-08-05. Retrieved 2015-04-03. "History of the Cossacks 15–21st centuries". Open Public Library. Documents, maps, illustrations Peeling, Siobhan. "Cossacks". "International Encyclopedia of the First World War". 1914–1918 online. Archived from the original on 2019-12-30. Retrieved 2019-06-18.
Suborder † Ceratitina Suborder † Phylloceratina Suborder † Lytoceratina Suborder † Ammonitina Subsequent revisions include the establishment of three Upper Cambrian orders, the Plectronocerida, Protactinocerida, and Yanhecerida; separation of the pseudorthocerids as the Pseudorthocerida, and elevating orthoceratid as the Subclass Orthoceratoidea.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue protein, while TB-500 matches only residues 17 to 23 of that chain. The two are related but differ in size, and a method that identifies one does not automatically identify the other.
It corresponds to the actin-binding region of thymosin beta-4. Commercial synthesis reproduces that seven-residue stretch, usually with an acetyl group on the N-terminus.
It is not authorised as a medicine in the United States or the European Union and is distributed as a research chemical. Labels consequently carry research-use-only statements rather than clinical indications.
Divide it into single-use aliquots and hold them frozen at -20 °C or below, protected from light. Repeated thawing of one container is the main avoidable source of variability.